(Press-News.org) New Rochelle, NY, September 19, 2023—Mary Ann Liebert, Inc. announces the launch of Journal of Medical Extended Reality (JMXR), the new open access peer-reviewed research journal dedicated to the advancement of extended reality in medicine. JMXR is launching in partnership with the American Medical Extended Reality Association (AMXRA), the premier medical society advancing the science and practice of medical extended reality, as their Official Journal. The journal welcomes your submission and will consider virtual, augmented, and mixed reality research, alongside other emerging technologies.
Spearheaded by Editor-in-Chief Dr. Brennan Spiegel, Professor of Medicine and Director of Health Services Research at Cedars-Sinai, where he created the Virtual Medicine program dedicated to studying XR in medicine, the Journal’s mission is to centralize research to stimulate innovative approaches, promote evidence-based practices, and drive the adoption of XR technologies in healthcare settings.
“The significance of Journal of Medical Extended Reality (JMXR) lies in our collective pursuit of unlocking the potential of Medical XR, while ensuring rigorous scientific scrutiny and the highest standards of evidence-based research,” says Dr. Brennan Spiegel. “The Journal will serve as an essential catalyst to clinicians, researchers, technologists, and policymakers for the accelerated growth of Medical XR, promoting critical dialogue, ethical considerations, and the dissemination of invaluable expertise.”
“We are thrilled to partner with Mary Ann Liebert on the creation of JMXR,” states Mark Zhang DO MMSc, President and Founder of the American Medical Extended Reality Association. “As the leading society dedicated to advancing the science and practice of medical extended reality, we believe JMXR represents a foundational contribution to the field of medical extended reality and will become the journal of record for the specialty.”
Journal of Medical Extended Reality invites submissions on a wide range of topics related to XR in medicine including but not limited to:
Clinical application of XR in neurology, psychology, and pain management
Uses of XR in medical, pediatric, and surgical subspecialities
Artificial intelligence in medical XR
Medical education, including virtual anatomy and immersive simulation platforms
Therapeutics and rehabilitation, including pain management and mental health
Human-Computer interaction and user experience for ergonomics and ethics
Regulatory implementation such as economics and insurance coverage for XR
We encourage the submission of original research articles, systematic reviews, meta-analyses, and case studies on the use of extended reality in medicine. Our Editorial Board consists of experts in the field of medical extended reality who have a broad range of expertise and experience in academia, industry, and clinical practice and who will ensure that all submissions are reviewed by peers from the scholarly community of extended reality. This team will ensure the highest standards of scientific rigor and transparency.
The Journal of Medical Extended Reality is dedicated to advancing the field by promoting research, collaboration, and knowledge exchange among interdisciplinary professionals. By embracing the potential of XR in healthcare, the Journal serves as an essential resource for a broad range of individuals, including medical researchers, healthcare professionals, educators, technology developers, administrators, students, industry professionals, ethicists, legal experts, and patient groups, all seeking to understand the latest advancements and applications of XR in the medical field and revolutionize the practice of medicine.
By aggregating this previously disparate research into one peer-reviewed forum entirely dedicated to medical extended reality, the Journal is determined to help professionals in the healthcare field learn how to utilize XR solutions in their everyday work. As healthcare continues to advance, the Journal will be on the cutting edge of advancing healthcare’s virtual frontiers.
For more information about AMXRA, visit their website. Members of AMXRA will have Article Processing Charges (APCs) waived for the first year of JMXR, and a membership discount on the APC fee moving forward.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, public health and policy, and technology and engineering. For complete information, please visit the Mary Ann Liebert, Inc. website.
END
Brennan Spiegel, MD, MSHS appointed Editor-in-Chief of new open access journal, Journal of Medical Extended Reality
2023-09-19
ELSE PRESS RELEASES FROM THIS DATE:
Training the gut’s immune system to combat detrimental effects of emulsifiers in processed food
2023-09-19
In a new study, mice whose immune systems were trained against the microbial protein flagellin did not experience the usual detrimental effects of ingesting food additive emulsifiers, pointing to a potential new way to combat various chronic inflammatory diseases. Melissa Kordahi and Benoit Chassaing, Inserm researchers from the Institut Cochin and Université Paris Cité, France, and colleagues present these findings September 19th in the open access journal PLOS Biology.
Dietary emulsifiers are substances added to processed food products to prevent mixed ingredients from separating. Prior research has suggested that eating certain emulsifiers ...
RNA for the first time recovered from an extinct species
2023-09-19
A new study shows the isolation and sequencing of more than a century-old RNA molecules from a Tasmanian tiger specimen preserved at room temperature in a museum collection. This resulted in the reconstruction of skin and skeletal muscle transcriptomes from an extinct species for the first time. The researchers note that their findings have relevant implications for international efforts to resurrect extinct species, including both the Tasmanian tiger and the woolly mammoth, as well as for studying pandemic RNA viruses.
The Tasmanian ...
New recipes for origin of life may point way to distant, inhabited planets
2023-09-19
Life on a faraway planet — if it’s out there — might not look anything like life on Earth. But there are only so many chemical ingredients in the universe’s pantry, and only so many ways to mix them. A team led by scientists at the University of Wisconsin–Madison has exploited those limitations to write a cookbook of hundreds of chemical recipes with the potential to give rise to life.
Their ingredient list could focus the search for life elsewhere in the universe by pointing out the most likely conditions — planetary versions of mixing techniques, oven temperatures and baking times — for the recipes to come together.
The process ...
STUDY: Cancer misinformation on TikTok could be harmful to women’s health
2023-09-19
Millions of women are turning to the social media platform TikTok for health advice related to gynecologic cancers, but the majority of that information is misleading or dramatically inaccurate, according to a new study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in the journal Gynecologic Oncology.
Senior study author Laura Chambers, DO, says this highlights the power of social media to feed misinformation that could be ...
The latest in science and medical advancement in otolaryngology-head and neck surgery to be presented at AAO-HNSF Annual Meeting
2023-09-19
Alexandria, Virginia — The latest research and advances in otolaryngology-head and neck surgery will be presented in Nashville, Tennessee, during the AAO-HNSF 2023 Annual Meeting & OTO Experience, September 30 – October 4. From among the hundreds of research presentations submitted for the 2023 Annual Meeting, the Annual Meeting Program Committee (AMPC), comprised of physician members, selected 16 Scientific Oral Presentations as the Best of Orals, as well as an additional 40 Late-Breaking abstract submissions that were added to the Scientific Oral Presentation program to offer the latest and most ...
$7 million in new grants propel Tufts Lyme research to next level
2023-09-19
Researchers at the Tufts Lyme Disease Initiative recently received grants totaling more than $7 million to build on an already impressive array of discoveries that Tufts’ teams have made to combat tick-borne diseases.
While Lyme disease can often be successfully treated with antibiotics, 10-20% of patients experience persistent fatigue, joint pain, and mental impairments that last months or years. For some, it is never clear whether symptoms signal persistent infection, reinfection, or malfunction by the body’s immune system.
Researchers ...
Leading the way in global STI research
2023-09-19
Researchers in the University of Delaware College of Health Sciences Department of Medical and Molecular Sciences are playing a pivotal role on the global health stage as they investigate the most common sexually transmitted infection (STI) in the world.
Centers for Disease Control statistics show that 79 million Americans have human papillomavirus (HPV). With 14 million new infections each year, 80% of women will get at least one type of HPV at some point in their lifetime, according to the Office on Women’s ...
NIH releases strategic plan for research on herpes simplex virus 1 and 2
2023-09-19
WHAT:
In response to the persistent health challenges of herpes simplex virus 1 (HSV-1) and HSV-2, today the National Institutes of Health released the Strategic Plan for Herpes Simplex Virus Research. An NIH-wide HSV Working Group developed the plan, informed by feedback from more than 100 representatives of the research and advocacy communities and interested public stakeholders. The plan outlines an HSV research framework with four strategic priorities: improving fundamental knowledge of HSV biology, pathogenesis, and epidemiology; accelerating research to improve HSV diagnosis; improving strategies to treat HSV while seeking a curative therapeutic; and, advancing research ...
Early convalescent plasma use — helpful in avoiding severe COVID — also may lower long COVID risk
2023-09-19
Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions — commonly known as long COVID — if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.
The new research, first posted online today in mBio, a journal from the American Society for Microbiology, is a follow-up investigation to the 2021 clinical trial that showed convalescent plasma ...
Machine learning analysis of research citations highlights importance of federal funding for basic scientific research
2023-09-19
Biomedical research aimed at improving human health is particularly reliant on publicly funded basic science, according to a new analysis boosted by artificial intelligence.
“What we found is that even though research funded by the National Institutes of Health makes up 10% of published scientific literature, those published papers account for about 30% of the substantive research — the important contributions supporting even more new scientific findings — cited by further clinical research ...